Top Stories

Porinju Veliyath Portfolio: Investors turn profits in small-cap pharma stocks

 

Porinju Veliyath has exited this stock after holding it for almost a year.

• Porinju Veliyath Portfolio: Investor name is missing in the company's shareholding pattern for Q2FY23

Porinju Veliyath Portfolio: A jar of small-cap stocks, Porinju Veliath has booked profit in his pharma stock Cupid Ltd. The name of the ace investor is missing from the shareholding pattern of the company for the period July to September 2022. However, his company name Equity Intelligence India Pvt Ltd was present in the company's shareholding pattern for the April to June 2022 quarter.

Porinju Veliyath's stake in Cupid

As per the shareholding pattern of Cupid for the period July to September 2022, the name of the company of Porinju Veliyath is missing, while it was present in the shareholding pattern of the company for the period Q1FY22. In the company's shareholding pattern for the first quarter of the current financial year, Porinju Veliyath held 1.70 lakh shares of the company, which was 1.27 per cent of the total paid-up capital of the company.

This means, the founder of Equity Intelligence India booked profit in this small-cap pharma stock or he sold the shares of the company to such an extent that his holding in the pharma company becomes less than 1 per cent of the total paid-up capital. company.

As per stock exchange rules, it is mandatory for a listed company to share the names of every shareholder who holds 1 percent or more of the company's shares. However, they are not bound to share the details of purchase and sale of shares. Therefore, it would be difficult to ascertain whether the investor sold his entire stake in the company or he booked a partial profit in the company. But, it is certain that during the second quarter of the current financial year, a jar of small-cap stock has booked profits in this small-cap pharma stock.

Cupid Share Price History

The medical research company's stock has given a tacit return to its positional shareholders. In the past six months, this small-cap stock has lost around 15 per cent, while in YTD time, it has given a return of 4 per cent to its investors. In fact, it has given zero returns to its shareholders in the last one year.

No comments: